SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-016110
Filing Date
2018-11-14
Accepted
2018-11-14 16:27:11
Documents
58
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1119896
2 ex31-1.htm EX-31.1 18352
3 ex32-1.htm EX-32.1 7808
  Complete submission text file 0001493152-18-016110.txt   4419089

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE aker-20180930.xml EX-101.INS 635414
5 XBRL SCHEMA FILE aker-20180930.xsd EX-101.SCH 63297
6 XBRL CALCULATION FILE aker-20180930_cal.xml EX-101.CAL 56694
7 XBRL DEFINITION FILE aker-20180930_def.xml EX-101.DEF 186332
8 XBRL LABEL FILE aker-20180930_lab.xml EX-101.LAB 421096
9 XBRL PRESENTATION FILE aker-20180930_pre.xml EX-101.PRE 278761
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 181184317
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1